ACH
Accendra Health, Inc.
ACH lost money over the past year, so it has no meaningful PE right now. Analysts expect a turn to a loss.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
ACH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Weak |
ACH's profitability is currently stable, but its revenue, cash flow and balance sheet are under pressure.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
ACH PE Valuation
ACH has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
ACH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect ACH's earnings and profitability to decline, with its revenue holding steady.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
HIMS has the edge over ACH on the outlook, with more favorable revenue and profitability expectations.
ACH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.24 | +$15.17 |
| Q2 2026 | -$3.93 | +$11.71 |
| Q1 2026 | -$14.07 | -$9.31 |
| Q4 2025 | -$14.31 | -$9.58 |
| Q3 2025 | -$17.41 | -$16.76 |
| Q2 2025 | -$15.64 | -$15.08 |
| Q1 2025 | -$4.76 | -$4.25 |
| Q4 2024 | -$4.73 | -$4.19 |
ACH is still losing money, but far less than before: $2.24 per share over the past year, against $17.41 at its worst in late 2025.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over ACH on earnings, with more consistent year-over-year improvement.
ACH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $601.8M | -14% |
| Q2 2026 | $613.2M | -10% |
| Q1 2026 | $627.8M | -76% |
| Q4 2025 | $709M | -74% |
| Q3 2025 | $697.3M | -74% |
| Q2 2025 | $681.9M | -74% |
| Q1 2025 | $2.6B | +0.7% |
| Q4 2024 | $2.7B | +1.5% |
ACH's revenue has slid since its 2024 peak: $602M last quarter, down 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.2% | -3.6 points |
| Q2 2026 | -5.7% | +0.1 points |
| Q1 2026 | 2.7% | +2.7 points |
| Q4 2025 | 3% | +13 points |
| Q3 2025 | 3.8% | +2.9 points |
| Q2 2025 | -5.8% | -6.6 points |
| Q1 2025 | 0% | -0.4 points |
| Q4 2024 | -9.7% | -12 points |
ACH has the edge over HIMS on profitability, with a higher operating margin.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over ACH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was โ7.4% last quarter, down 9.4 points from the same quarter a year ago.
ACH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$56.6M | +$170.2M |
| Q1 2026 | -$91.7M | -$56.7M |
| Q4 2025 | $55.1M | +574% |
| Q3 2025 | -$226.8M | -$192.6M |
| Q1 2025 | -$35.1M | +$63.9M |
| Q4 2024 | $8.2M | -87% |
| Q3 2024 | -$34.2M | -132% |
| Q2 2024 | $70.3M | -73% |
ACH has burned cash in six of the last eight quarters: โ$167M over the past year, against โ$288M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over ACH on cash generation, producing positive trailing cash flow while its opponent burns cash.
ACH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.6x | High |
| Q2 2026 | 6.8x | High |
| Q1 2026 | 7.4x | High |
| Q4 2025 | 8.0x | High |
| Q1 2025 | 54.7x | High |
| Q4 2024 | 31.7x | High |
| Q3 2024 | 4.8x | High |
| Q2 2024 | 4.6x | High |
ACH's net debt is about 8.6 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
ACH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.1 | Oversold |
| Stochastic | 1.0 | Oversold |
ACH's weekly RSI is 24 (oversold) and its Stochastic is 1 (oversold).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
ACH PE vs Healthcare Sector
| Metric | ACH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | โ |
ACH has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | โ |
HIMS has no meaningful PE right now: it lost money over the past year.
ACH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.34 | 56% below |
| 20 week MA | $1.44 | 90% below |
| 50 week MA | $2.21 | 93% below |
| 100 week MA | $4.90 | 97% below |
| 200 week MA | $11.4 | 99% below |
ACH is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
ACH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.08 | $30.3 | +497% |
| 2021 | $30.3 | $43.7 | +44% |
| 2022 | $43.7 | $19.5 | -55% |
| 2023 | $19.5 | $19.3 | -1% |
| 2024 | $19.3 | $13.0 | -33% |
| 2025 | $13.0 | $2.77 | -79% |
| 2026 YTD | $2.77 | $0.15 | -95% |
ACH has finished four years in a row lower, and it's down 95% so far in 2026.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over ACH on returns for 2026, with the stronger performance.